Archives
607, 2026
Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser® IFX for ZYMFENTRA® (infliximab-dyyb)
News & Events Celltrion USA [...]
305, 2026
Prometheus Signals Near Term Development of Next Generation Noninvasive Test for MASH Patients at DDW® 2026
News & Events Prometheus Signals [...]
205, 2026
Prometheus Laboratories Showcases Drug Clearance as a Foundation for Precision Guided Biologic Dosing in IBD at DDW® 2026
News & Events Prometheus Laboratories [...]
812, 2025
Prometheus Laboratories Launches IBD Precis™ Featuring Breakthrough Colonic Markers to Transform UC and CD Assessment
News & Events Prometheus Laboratories [...]
2608, 2025
Prometheus Laboratories Announces Collaboration with Celltrion for Anser® Testing
News & Events Prometheus Laboratories [...]
2907, 2025
Prometheus Laboratories Expands Precision-Guided Dosing Tests with the Launch of PredictrPK® VDZ and UST
News & Events Prometheus Laboratories [...]